Premium
New medications and new ways to use them
Author(s) -
Ryan Donna H.
Publication year - 2015
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.21091
Subject(s) - weight loss , medicine , phentermine , liraglutide , bupropion , weight management , best practice , orlistat , topiramate , alternative medicine , intervention (counseling) , family medicine , smoking cessation , obesity , psychiatry , management , pathology , diabetes mellitus , type 2 diabetes , economics , epilepsy , endocrinology
The field of obesity pharmacotherapy is in its infancy. While these drugs represent new tools to use to help patients in chronic obesity management, we need an educated and more experienced group of prescribers. Only then can we have a meaningful impact on the chronic disease risk driven by obesity. Understanding the basic principles of using obesity medication is the first step in that direction.